A study of influence of iron deficiency anemia on levels of HbA1c among nondiabetic patients in a tertiary care hospital.
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2020 - 2022
Project Lead
Ashmita Khadk
Authors
Ashmita Khadka, Jyothi D N, Vinod George Thykadavil
Project Status
completed
Project Type
Student Project